Drug Designing and Biomarkers
Drug designing is an inventive process to find new medication centred on the knowledge of biological target. Drug is most commonly a small molecule that inhibits or activates the function of a biomolecule, which in turn outcomes in a therapeutic benefit to the patient. Drug design commonly but not essentially relies on computational techniques. This type of modelling is often mentioned to as computer-aided drug design.
A biomarker is an attribute that can be studied as an indicator of pathogenic and biological operation along with pharmacological retort to a therapeutic involvement. They indicate either normal or diseased activity in the body. Biomarkers are specific molecules, genes, gene products, hormones, cells or enzymes.
- Drug targets
- Ligand-based design
- Structure-based design
- Computer-aided drug design
- Scoring functions
Related Conference of Drug Designing and Biomarkers
Drug Designing and Biomarkers Conference Speakers
Recommended Sessions
- 3-D Structure Determination
- Advancements in structural Biology
- Biochemistry and Biophysics
- Computational Approach in Structural Biology
- Drug Designing and Biomarkers
- Frontiers in Structural Biology
- Gene regulation and Cell Signalling
- Hybrid Approaches in structure prediction
- Molecular Biology
- Molecular biology techniques
- Molecular Modelling and Dynamics
- Proteomics and Genomics
- Sequencing analysis
- Structural Bioinformatics
- Structural Biology
- Structural biology databases
- Structural Biology in Cancer Research
- Structural enzymology
Related Journals
Are you interested in
- 3D Structure Determination - Structural Biology-2026 (France)
- Advanced Imaging and Super-Resolution Techniques - Structural Biology 2026 (Spain)
- Advanced Techniques in Structural Biology - Structural Biology-2026 (France)
- AI & Computational Structural Biology - Structural Biology-2026 (France)
- Biochemistry and Biophysics - Structural Biology-2026 (France)
- Biomolecular Dynamics and Allostery - Structural Biology 2026 (Spain)
- Computational Approach in Structural Biology - Structural Biology-2026 (France)
- Computational Structural Biology and Artificial Intelligence - Structural Biology 2026 (Spain)
- Cryo-Electron Microscopy (Cryo-EM) - Structural Biology 2026 (Spain)
- Drug Designing and Biomarkers - Structural Biology-2026 (France)
- Hybrid Approaches for Structure Prediction - Structural Biology-2026 (France)
- Integrative and Hybrid Structural Biology - Structural Biology 2026 (Spain)
- Membrane Protein Structure and Dynamics - Structural Biology 2026 (Spain)
- Membrane Proteins and Receptors - Structural Biology-2026 (France)
- Molecular Modelling and Dynamics - Structural Biology-2026 (France)
- Nuclear Magnetic Resonance (NMR) Spectroscopy - Structural Biology 2026 (Spain)
- Protein Engineering and Synthetic Biology - Structural Biology 2026 (Spain)
- Protein Structure and Function - Structural Biology 2026 (Spain)
- Proteomics and Genomics - Structural Biology-2026 (France)
- Structural Basis of Genetic and Metabolic Disorders - Structural Biology 2026 (Spain)
- Structural Bioinformatics and Computational Biology - Structural Biology-2026 (France)
- Structural Biology in Cancer Research - Structural Biology-2026 (France)
- Structural Biology in Drug Discovery - Structural Biology 2026 (Spain)
- Structural Genomics and Proteomics - Structural Biology 2026 (Spain)
- Structural Immunology - Structural Biology 2026 (Spain)
- Structural Virology - Structural Biology-2026 (France)
- Structural Virology and Infectious Diseases - Structural Biology-2026 (France)
- Structure-Based Drug Discovery - Structural Biology-2026 (France)
- Structure-Based Solutions to Global Health Challenges - Structural Biology-2026 (France)
- Structure-Function Relationships - Structural Biology-2026 (France)
- The Structural Basis of Disease - Structural Biology-2026 (France)
- Virus Structure and Host Interactions - Structural Biology 2026 (Spain)
- X-ray Crystallography and Diffraction Methods - Structural Biology 2026 (Spain)
